Clinical trial · Observational
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
A Feasibility Study for Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical research study is to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer. Researchers will study the possible reason for these symptoms by drawing blood samples and comparing the test results to the symptoms you experience. The study will also use a special telephone system for measuring the symptoms of participants during and after therapy. Your level of physical activity will also be studied using a pedometer and study diary.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood Draws | Procedure | — | UNRESOLVED |
| Pedometer | Device | — | UNRESOLVED |
| Questionnaires | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Symptom Study
- description
- Questionnaires + Blood Draw + Pedometer used to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer.
- interventionNames
- Behavioral: Questionnaires
- Procedure: Blood Draws
- Device: Pedometer
Primary outcomes (1)
- measure
- Patient Reported Symptom Severity and Interference
- timeFrame
- Weekly for 8 cycles of chemotherapy, followed by twice a month for 14 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients must have histologically or cytologically confirmed cancer of the pancreas. 2. Patients must have inoperable locally advanced or metastatic disease. 3. Patients could be on treatment, or being planned for chemotherapy treatment. 4. Age 18 years of age or older 5. ECOG performance status 0-3 6. Ability to give consent in either English or Spanish Exclusion Criteria: 1. Any condition (including unwillingness) that would impair the patient's ability to utilize the IVR system 2. Any recent surgical procedures (within 14 days, excluding biopsy, port-a-cath or picc line placement)
References
Publications (0)
Data not yet available